Recurrent drug shortages signal onerous outlook for cardiovascular care
Pharmaceutical Technology
NOVEMBER 3, 2022
Genentech, a subsidiary of Roche , markets alteplase and tenecteplase under the names Activase and TNKase in the US, while Boehringer sells them under the names Actilyse and Metalyse in the EU. According to some estimates, between 2017 and 2047, the number of individuals living with stroke will increase by 27% in the EU.
111 
Let's personalize your content